Danielle M. Townsley

3.7k total citations · 1 hit paper
64 papers, 2.2k citations indexed

About

Danielle M. Townsley is a scholar working on Hematology, Molecular Biology and Physiology. According to data from OpenAlex, Danielle M. Townsley has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 19 papers in Molecular Biology and 16 papers in Physiology. Recurrent topics in Danielle M. Townsley's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (20 papers) and Telomeres, Telomerase, and Senescence (14 papers). Danielle M. Townsley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (20 papers) and Telomeres, Telomerase, and Senescence (14 papers). Danielle M. Townsley collaborates with scholars based in United States, Brazil and Japan. Danielle M. Townsley's co-authors include Neal S. Young, Bogdan Dumitriu, Cynthia E. Dunbar, Phillip Scheinberg, Colin O. Wu, Katherine R. Calvo, Ronan Desmond, Xingmin Feng, Thomas Winkler and Margaret Bevans and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Danielle M. Townsley

62 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

2017 337 citations Danielle M. Townsley, Phillip Scheinberg et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle M. Townsley United States	23	1.4k	550	457	437	383	64	2.2k
K Sawada Japan	25	1.1k 0.8×	552 1.0×	497 1.1×	490 1.1×	571 1.5×	60	2.4k
Barbara Weinstein United States	20	1.0k 0.7×	250 0.5×	214 0.5×	236 0.5×	257 0.7×	50	1.8k
Fumio Bessho Japan	29	1.1k 0.8×	230 0.4×	863 1.9×	239 0.5×	286 0.7×	102	2.4k
Nigel Westwood United Kingdom	21	913 0.7×	349 0.6×	767 1.7×	138 0.3×	862 2.3×	68	2.2k
Laura L. Swystun Canada	20	815 0.6×	659 1.2×	454 1.0×	85 0.2×	192 0.5×	47	2.0k
Taeko Ishii Japan	18	440 0.3×	629 1.1×	335 0.7×	222 0.5×	243 0.6×	54	2.0k
David Peace United States	27	650 0.5×	864 1.6×	422 0.9×	116 0.3×	396 1.0×	79	2.1k
Janusz Kłoczko Poland	20	1.1k 0.8×	423 0.8×	363 0.8×	85 0.2×	659 1.7×	119	2.1k
LL Sensenbrenner United States	24	1.2k 0.9×	525 1.0×	376 0.8×	136 0.3×	426 1.1×	67	2.0k
G. Girelli Italy	23	531 0.4×	354 0.6×	234 0.5×	348 0.8×	422 1.1×	106	1.8k

Countries citing papers authored by Danielle M. Townsley

Since Specialization

Citations

This map shows the geographic impact of Danielle M. Townsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle M. Townsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle M. Townsley more than expected).

Fields of papers citing papers by Danielle M. Townsley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle M. Townsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle M. Townsley. The network helps show where Danielle M. Townsley may publish in the future.

Co-authorship network of co-authors of Danielle M. Townsley

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle M. Townsley. A scholar is included among the top collaborators of Danielle M. Townsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle M. Townsley. Danielle M. Townsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maris, Michael B., Gilles Salles, Won Seog Kim, et al.. (2024). ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study. Targeted Oncology. 19(3). 321–332. 4 indexed citations

Goldman, Jonathan W., Sarina A. Piha‐Paul, Brendan D. Curti, et al.. (2022). Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research. 28(17). 3709–3719. 19 indexed citations

Glisson, Bonnie S., Rom S. Leidner, Robert L. Ferris, et al.. (2020). Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research. 26(20). 5358–5367. 63 indexed citations

Fan, Xing, Ronan Desmond, Thomas Winkler, et al.. (2020). Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Advances. 4(8). 1700–1710. 32 indexed citations

Alvarado, Luigi J., Heather D. Huntsman, Hai Cheng, et al.. (2019). Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ. Blood. 133(19). 2043–2055. 80 indexed citations

Cheruku, Patali S., Ayla Cash, Richard H. Smith, et al.. (2019). Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells. Experimental Hematology. 73. 1–6.e6. 15 indexed citations

Gutierrez‐Rodrigues, Fernanda, Flávia S. Donaires, Laura W. Dillon, et al.. (2018). Pathogenic TERT promoter variants in telomere diseases. Genetics in Medicine. 21(7). 1594–1602. 30 indexed citations

Pore, Nabendu, Kevin Schifferli, Noel R. Monks, et al.. (2018). Discovery and Development of MEDI7247, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate Targeting ASCT2, for Treating Hematological Cancers. Blood. 132(Supplement 1). 4071–4071. 7 indexed citations

Glisson, Bonnie S., Rom S. Leidner, Robert L. Ferris, et al.. (2018). Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors. Annals of Oncology. 29. viii410–viii410. 20 indexed citations

10.

Dulau‐Florea, Alina, Neal S. Young, Irina Marić, et al.. (2018). Bone Marrow as a Source of Cells for Paroxysmal Nocturnal Hemoglobinuria Detection. American Journal of Clinical Pathology. 150(3). 273–282. 3 indexed citations

11.

McReynolds, Lisa J., Yanqin Yang, Hong Yuen Wong, et al.. (2018). MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. Leukemia Research. 76. 70–75. 32 indexed citations

12.

Giudice, Valentina, Xin Zhao, Zhijie Wu, et al.. (2018). Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing. Blood Cells Molecules and Diseases. 69. 10–22. 5 indexed citations

13.

Townsley, Danielle M., Phillip Scheinberg, Thomas Winkler, et al.. (2017). Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. New England Journal of Medicine. 376(16). 1540–1550. 337 indexed citations breakdown →

14.

Dumitriu, Bogdan, Sawa Ito, Xingmin Feng, et al.. (2015). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. The Lancet Haematology. 3(1). e22–e29. 39 indexed citations

15.

Hosokawa, Kohei, Pawel Muranski, Xingmin Feng, et al.. (2015). Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica. 100(12). 1534–1545. 35 indexed citations

16.

Townsley, Danielle M., Bogdan Dumitriu, & Neal S. Young. (2014). Bone marrow failure and the telomeropathies. Blood. 124(18). 2775–2783. 167 indexed citations

17.

Dumitriu, Bogdan, Xingmin Feng, Danielle M. Townsley, et al.. (2014). Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia. Blood. 125(4). 706–709. 58 indexed citations

18.

Hosokawa, Kohei, Pawel Muranski, Xingmin Feng, et al.. (2014). Altered microRNAs in T Cells from Patients with Acquired Aplastic Anemia. Blood. 124(21). 2940–2940. 1 indexed citations

19.

Desmond, Ronan, Danielle M. Townsley, Cynthia E. Dunbar, & Neal S. Young. (2014). Eltrombopag in Aplastic Anemia. Seminars in Hematology. 52(1). 31–37. 22 indexed citations

20.

Feng, Xingmin, Phillip Scheinberg, Angélique Biancotto, et al.. (2014). In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia. Haematologica. 99(9). 1433–1440. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact